Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04814420 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jul 2026 to Nov 2026v12
  2. Primary and study completion dates: Dec 2025 to Jul 2026
    • Study sites: 2 to 3
    v11
  3. Enrollment target: 20 to 60v10 Show 6 more changesShow less
    • Primary endpoint revised
    • Eligibility criteria expanded, about 39 words
    • Study description shortened, about 46 words
    • Study title revised
    • Study arms: 2 to 6
    • Secondary endpoints shortened, about 4 words
  4. Primary and study completion dates: Dec 2024 to Dec 2025
    • Study sites: 1 to 2
    v9
  5. Site contact updatedv8
Show 6 earlier versionsHide 6 earlier versions
  1. Primary and study completion dates: Jul 2022 to Dec 2024
    • Site contact updated
    v7
  2. Site contact updatedv6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jun 2022 to Jul 2022
    • Start date changed from estimate of Jun 2021 to Jul 12, 2021
    • Site details revised
    v5
  4. Primary and study completion dates: May 2022 to Jun 2022
    • Start date: May 2021 to Jun 2021
    v4
  5. Primary and study completion dates: Apr 2022 to May 2022
    • Start date: Apr 2021 to May 2021
    v3
  6. Study description expanded, about 1 wordv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).
Trial Details
NCT Number NCT04814420
Lead Sponsor Tulane University
Conditions
(from sponsor)		 Atrial Fibrillation, Obstructive Sleep Apnea
Related terms Atrial Fibrillation, Sleep Apnea, Obstructive
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov